Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Tool Uncovers 10 Times More Adverse Events Than Regular Methods

This article was originally published in The Gray Sheet

Executive Summary

Two methods commonly used to track patient safety in hospitals fail to detect more than 90% of adverse events, according to a study of 795 hospitalized patients.

You may also be interested in...



MDRs Hit All-Time High, But FDA Still Says Adverse Events Are Underreported

FDA’s device center is concerned that adverse events are being grossly underreported to its Medical Device Reporting (MDR) program. This comes despite manufacturers submitting a record number of MDRs last year.

MDRs Hit All-Time High, But FDA Still Says Adverse Events Are Underreported

FDA’s device center is concerned that adverse events are being grossly underreported to its Medical Device Reporting (MDR) program. This comes despite manufacturers submitting a record number of MDRs last year.

Regulatory News In Brief

Sentinel workshop

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030049

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel